Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Lina Somri"'
Autor:
Laris Achlaug, Lina Somri-Gannam, Shilhav Meisel-Sharon, Rive Sarfstein, Manisha Dixit, Shoshana Yakar, Mordechai Hallak, Zvi Laron, Haim Werner, Ilan Bruchim
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
The insulin-like growth factors (IGF) are important players in the development of gynecological malignancies, including epithelial ovarian cancer (EOC). The identification of biomarkers that can help in the diagnosis and scoring of EOC patients is of
Externí odkaz:
https://doaj.org/article/1afbe2b029f3461694ba8b14108ce8cf
Autor:
Lina Somri-Gannam, Shilhav Meisel-Sharon, Shay Hantisteanu, Gabriel Groisman, Ofer Limonad, Mordechai Hallak, Ilan Bruchim
Publikováno v:
Translational Oncology, Vol 13, Iss 8, Pp 100790- (2020)
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. The insulin-like growth factor (IGF) system plays a key role in regulating growth and invasiveness in several malignancies, including ovarian cancer. IGF1R targeting showed
Externí odkaz:
https://doaj.org/article/0b142bcdede445f0ab4d507e1f96b117
Autor:
Mostafa Somri, Ohad Hochman, Lina Somri-Gannam, Luis Gaitini, Alona Paz, Tami Bumard, Manuel Á. Gómez-Ríos
Publikováno v:
Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare.
Autor:
Lina Somri-Gannam, Shilhav Meisel Sharon, Shay Hantisteanu, Hallak Mordechai, Haim Werner, Ilan Bruchim
Publikováno v:
E-Posters.
Autor:
Haim Werner, Lena Lapkina-Gendler, Laris Achlaug, Karthik Nagaraj, Lina Somri, Danielle Yaron-Saminsky, Metsada Pasmanik-Chor, Rive Sarfstein, Zvi Laron, Shoshana Yakar
Publikováno v:
Cells, Vol 8, Iss 6, p 596 (2019)
Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency. The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical rele
Externí odkaz:
https://doaj.org/article/1cc8c0e9c5d54fddab17357e9c9106eb
Autor:
S. Hantisteanu, Mordechai Hallak, Gabriel M. Groisman, Ofer Limonad, Shilhav Meisel-Sharon, Ilan Bruchim, Lina Somri-Gannam
Publikováno v:
Translational Oncology
Translational Oncology, Vol 13, Iss 8, Pp 100790-(2020)
Translational Oncology, Vol 13, Iss 8, Pp 100790-(2020)
Epithelial ovarian cancer (EOC) is the most lethal gynecological malignancy. The insulin-like growth factor (IGF) system plays a key role in regulating growth and invasiveness in several malignancies, including ovarian cancer. IGF1R targeting showed
Autor:
Lena Lapkina-Gendler, Haim Werner, Zvi Laron, Lina Somri, Karthik Nagaraj, Rive Sarfstein, Leon A. Bach
Publikováno v:
Growth Hormone & IGF Research. 39:6-12
Laron syndrome (LS), or primary growth hormone (GH) insensitivity, is a growth disorder that results from mutation of the GH-receptor (GHR) gene leading to congenital insulin-like growth factor-1 (IGF-1) deficiency. Recent epidemiological studies hav
Autor:
Laris Achlaug, Lena Lapkina-Gendler, Shoshana Yakar, Zvi Laron, Haim Werner, Danielle Yaron-Saminsky, Lina Somri, Karthik Nagaraj, Rive Sarfstein, Metsada Pasmanik-Chor
Publikováno v:
Cells, Vol 8, Iss 6, p 596 (2019)
Cells
Cells
Laron syndrome (LS), or primary growth hormone resistance, is a prototypical congenital insulin-like growth factor 1 (IGF1) deficiency. The recent epidemiological finding that LS patients do not develop cancer is of major scientific and clinical rele
Autor:
Somri, Mostafa, Hochman, Ohad, Somri-Gannam, Lina, Gaitini, Luis, Paz, Alona, Bumard, Tami, Gómez-Ríos, Manuel Á.
Publikováno v:
Simulation in Healthcare; Jun2024, Vol. 19 Issue 3, p137-143, 7p
Autor:
Achlaug, Laris, Somri-Gannam, Lina, Meisel-Sharon, Shilhav, Sarfstein, Rive, Dixit, Manisha, Yakar, Shoshana, Hallak, Mordechai, Laron, Zvi, Werner, Haim, Bruchim, Ilan
Publikováno v:
Frontiers in Endocrinology; 6/18/2021, Vol. 12, p1-8, 8p